Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patients with non Hodgkin's lymphoma and acute lymphoblastic leukaemia

Leukemia and Lymphoma

Volumn 36, Issue 1-2, 1999, Pages 33-43

  Jerjis, S H ^a   Croockewit, S ^a   Muus, P ^a   Schaap, N ^a   Preijers, F ^a   De Witte, T ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autologous bone marrow transplantation; Autologous peripheral stem cell transplantation; Bone marrow recovery; Cost analysis; Lymphoproliferative malignancies

Indexed keywords

ACICLOVIR; AMPHOTERICIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; IDARUBICIN; MORPHINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BURST FORMING UNIT E; COLONY FORMING UNIT GM; COST BENEFIT ANALYSIS; COST CONTROL; CYTOPENIA; DRUG COST; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PARENTERAL NUTRITION; PRIORITY JOURNAL; SCHOOL CHILD; STEM CELL; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME;

EID: 0033459586     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909145947     Document Type: Article

References (46)

1. Wunder, E. W., Henon, P. R. (1993) Peripheral blood stem cell autograft. Berlin Heidelberg: Springer-verlag., pp3.
2. Fliedner, T. M., Flad, H. D., Bruch, C. et al. (1976) Treatment of aplastic anemia by blood stem cell transfusion: a canine model. Haematologica, 61, 141-156.
3. Goldman, J. M., Th'ng, K. H., Park, D. S. et al. (1978) Collection, cryopreservation and subsequent viability of haemopoietic stem cells intended for treatment of chronic granulocytic leukaemia in blast-cell transformation. Br J Haematol, 40, 185-195.
4. Korbling, M., Burke, P., Braine, H. et al (1981) Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia. Exp Hematol, 9, 684-690.
5. Juttner, C. A., To, L. B., Haylock, D. N. et al. (1985) Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br J Haematol, 61, 739-745.
6. Micklem, H. S., Anderson, N., Ross, E. et al. (1975) Limited potential of circulating haemopoietic stem cells. Nature, 256, 41-43.
7. Hibbin, J. A., Njoku, O. S., Matutes, B. et al. (1984) Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br J Haematol, 57, 495-503.
8. Korbling, M., Dorken, B., Ho, A. D. et al. (1986) Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood. 67, 529-532.
9. Gianni, A. M., Siena, S., Bregni, M. et al. (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet, 2, 580-585.
10. Fukuda, M., Kojima, S., Matsumoto, K. et al (1992) Autotransplantation of peripheral blood stem cells mobilized by chemotherapy and recombinant human granulocyte colony-stimulating factor in childhood neuroblastoma and non-Hodgkin's lymphoma. Br J Haematol, 80, 327-331.
11. Mahendra, P., Johnson, D., Scott, M. A. et al. (1996) Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients. Bone Marrow Transplant, 17, 503-507.
12. Bender, J. G., To, L. B., Williams, S. et al. (1992) Defining a therapeutic dose of peripheral blood stem cells. J Hematother, 1, 329-341.
13. Martino, M., Morabito, F., Messina, G. et al. (1996) Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica, 81, 59-61.
14. Gaspard, M. H., Maraninchi, D., Stoppa, A. M. et al. (1988) Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies. Cancer Chemother Pharmacol, 22, 256-262.
15. Mills, W., Chopra, R., McMillan A. et al. (1995) BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol, 13, 588-595.
16. Rapoport, A. P., Rowe, J. M., Kouides, P. A. et al. (1993) One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome. J-Clin Oncol. 11, 2351-2361.
17. Raemaekers, J., de Witte, T., Schattenberg, A. et al. (1989) Prevention of leukemic relapse after transplantation with lymphocyte depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclines. Bone Marrow Transplant, 4, 167-171.
18. Stockerl, G. K., Horning, S. J., Negrin, R. S. et al. (1996) Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation tor non-Hodgkin's lymphoma. Biol Blood Marrow Transplant, 2, 76-85.
19. Spitzer, T. R., Cottler, F., Torrisi, J. et al. (1989) Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation. Bone Marrow Transplant, 4, 559-565.
20. Coulombel, L., Kalousek, D. K., Eaves, C. J. et al. (1983) Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. N Engl J Med. 308, 1493-1498.
21. Gilbert, C. J. (1996) Peripheral blood progenitor cell transplantation for breast cancer: pharmacoeconomic considerations. Pharmacotherapy, 16, 101s-108s.
22. Inaba, S., Ohno, Y., Mizuno, S. et al. (1995) [The progress of autologous peripheral blood stem cell transplantation]. Nippon Rinsho, 53, 779-789.
23. Takaue, Y., Okamoto, Y., Kawano, Y. et al. (1994) Regeneration of immunity and varicella-zoster virus infection after high-dose chemotherapy and peripheral blood stem cell autografts in children. Bone Marrow Transplant, 14, 219-223.
24. Grenman, S. E., Rantanen, V. T., Salmi, T. A. et al. (1996) High-dose chemotherapy with autologous stem cell support in advanced ovarian cancer. Ann Med, 28, 151-158.
25. Fetscher, S., Brugger, W., Bertz, H. et al. (1997) High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcoma. Bone Marrow Transplant, 20, 787-788.
26. Feischer, S., Brugger, W., Engelhardt, R. et al. (1997) Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer. Ann Oncol, 8, 49-56.
27. Fetscher, S., Brugger, W., Engelhardt, R. et al. (1997) Dose-intense therapy with etoposide, ifosfamide, cisplatin. and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-disease non-small-cell lung cancer. Ann Oncol, 8, 57-64.
28. Fetscher, S., Kiani, A., Kanz, L. et al. (1996) Neo-adjuvant high-dose chemotherapy with autologous peripheral blood stem cell transplantation for inoperable relapse of nuchal liposarcoma resistant to standard-dose chemotherapy [letter] Ann Oncol, 7, 871.
29. Smith, T. J., Hillner, B. E., Schmitz, N. et al. (1997) Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma. J Clin Oncol. 15, 5-10.
30. Hartmann, O., le Corroller, A.G., Blaise, D. et al. (1997) Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial. Ann Intern Med, 126, 600-607.
31. Henon, P., Donatini, B., Eisenmann, J. C. et al. (1995) Comparative survival, quality of life and cost-effectiveness of intensive therapy with autologous blood cell transplantation or conventional chemotherapy in multiple myeloma. Bone Marrow Transplant, 16, 19-25.
32. Duncan, N., Hewetson, M., Powles, R. et al. (1996) An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma. Bone Marrow Transplant, 18, 1175-1178.
33. Faucher, C., le Corroller, A. G., Blaise, D. et al. (1994) Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness. Bone Marrow Transplant, 14, 895-901.
34. Rio, B., Marjanovic, Z., Belhocine, R. et al. (1996) [Difference in costs of autologous transplantation of peripheral and bone marrow hematopoietic stem cells. A retrospective analysis over 1 year of transplantation in lymphoma, Hodgkin's disease and myeloma in a Center] Difference de cout des autogreffes de cellules-souches hematopoietiques circulantes et medullaires. Ann Med Interne Paris, 147, 313-319.
35. Julia, A., Bueno, J., Gadea, N. et al. (1995) [Economic study of the cost of peripheral blood hematopoietic precursor autotransplantation compared with hone marrow transplantation]. Med Clin Barc, 105, 131-135.
36. Bennett, C. L., Armitage, J. L., Armitage, G. O. et al. (1995) Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991. J Clin Oncol, 13, 969-973.
37. Lawless, G. D. (1995) Cost-effectiveness of autologous bone marrow transplantation. Am J Health Syst Pharm, 52, S11-S14.
38. Jones, H. M., Jones, S. A., Watts, M. J. et al. (1944) Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J. Clin Oncol., 12, 1693-1702.
39. Souetre, E., Qing, W., Penelaud, P. F. et al. (1996) Economic analysis of the use of recombinant human granulocyte colony stimulating factor in autologous bone marrow transplantation. Eur J -Cancer, 32a, 1162-1165.
40. Klumpp, T. R., Mangan, K. F., Goldberg, S. L. et al. (1995) Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. J -Clin Oncol. 13, 1323-1327.
41. Gulati, S., Bennett, C., Toia, M. et al. (1993) Role of granulocyte-macrophage colony stimulating factor (GM-CSF) after autologous bone marrow transplantation for Hodgkin's disease. Anticancer Drugs, 1, 13-16.
42. Weaver, A., Ryder, D., Crowther, D. et al. (1996) Increased numbers of long-term culture-initiating cells in the apheresis product of patients randomized to receive increasing doses of stem cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony-stimulating factor. Blood, 88, 3323-3328.
43. Glaspy, J. A., Shpall, E. J., LeMaistre, C. F. et al. (1997) Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood, 90, 2939-2951.
44. Weaver, C. H., Hazelton, B., Birch, R. et al. (1995) An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood, 86, 3961-3969.
45. Ketterer, N., Salles, G., Raba, M. et al. (1998) High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation. Blood, 91, 3148-3155.
46. Gonzalez, R., Madero, L., Diaz, M. A. et al. (1998) Progenitor cell subsets and engraftment kinetics in children undergoing autologous peripheral blood stem cell transplantation. Br J Haematol, 101, 104-110.